Entrepreneur Briefs

The dispute itself isn’t unique: three scientists are accused of stealing trade secrets after they left a research institute for positions in industry. But this dispute is taking place in China, where the outcome may have an important impact on the future of entrepreneurship in a state-controlled economy. The China Research Institute for Printing Science and Technology has accused three senior researchers of taking with them their work on advanced typesetting software when they accepted

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The dispute itself isn’t unique: three scientists are accused of stealing trade secrets after they left a research institute for positions in industry. But this dispute is taking place in China, where the outcome may have an important impact on the future of entrepreneurship in a state-controlled economy. The China Research Institute for Printing Science and Technology has accused three senior researchers of taking with them their work on advanced typesetting software when they accepted jobs with a Chinese firm, Stone Corp., in 1986. A four-year-old collective company located near 150 other technology firms in China’s “Silicon Valley” northwest of Beijing, Stone exports sophisticated printer equipment and has been extolled by the official media as a model of nonstate enterprise. China’s Intermediate People’s Court, asked to rule on the institute’s complaint, could find itself in a lose-lose situation. Observers say that a decision in favor of Stone would tempt scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies